Uncategorized
2021 Report on the Keratoconjunctivitis Sicca Drugs In Development – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Keratoconjunctivitis sicca (Dry Eye) (Ophthalmology) - Drugs In Development, 2021" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of the Keratoconjunctivitis Sicca (Ophthalmology) pipeline landscape. Keratoconjunctivitis sicca (KCS) or dry eye disease (DED) or dry eye syndrome (DES) is a condition in which a person experience desiccation of the conjunctiva and cornea due to an inadequate tear film. Symptoms include hype